KRAS insertion mutations are oncogenic and exhibit distinct functional properties
Amino acid substitutions in K-Ras that constitutively activate the protein are common in cancer. Here, the authors describe mutations in the K-RasSwitch 2 domain and show that the mutant proteins accumulate in the active conformation, exhibit defective binding to PI3 kinase, and are hypersensitive t...
Enregistré dans:
Auteurs principaux: | Yasmine White, Aditi Bagchi, Jessica Van Ziffle, Anagha Inguva, Gideon Bollag, Chao Zhang, Heidi Carias, David Dickens, Mignon Loh, Kevin Shannon, Ari J. Firestone |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c8ee34111da64f238c6f182195674d48 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Oncogenic KRAS: Signaling and Drug Resistance
par: Hyeon Jin Kim, et autres
Publié: (2021) -
Immune modulatory effects of oncogenic KRAS in cancer
par: Shaima’a Hamarsheh, et autres
Publié: (2020) -
Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
par: Liu X, et autres
Publié: (2019) -
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
par: Gongmin Zhu, et autres
Publié: (2021) -
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
par: Naiara Santana-Codina, et autres
Publié: (2018)